Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)
Status:
Completed
Trial end date:
2021-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this investigation is to systematically study the efficacy of Tecfidera in
those individuals who possess incidental white matter anomalies within the brain following a
MRI study that is performed for a reason other than for the evaluation of MS (multiple
sclerosis).